EJNMMI Radiopharmacy and Chemistry · 2016 · 50 citations · 37 references
MedicinePharmaceuticsPharmacologyMolecular ImagingOrganometallic ChemistryRadionuclide TherapyBioconjugation ChemistryPeptide ChemistryRadiopharmaceuticalsRadiotracer DevelopmentBifunctional ChelatorsMild Reaction ConditionsPeptide RadiopharmaceuticalsPeptide-based RadiopharmaceuticalsPeptide-based RadiotracersPet RadiopharmaceuticalsRadionuclide ConjugationRadiotracer Synthesis
BACKGROUND: Ga-PET depends on our ability to develop radiopharmaceuticals that can be prepared in a convenient and suitable manner. A kit-type labelling protocol provides such characteristics and requires chelators that can be radiolabelled under exceptionally mild conditions. Recently the DATA chelators have been introduced that fulfil these requirements. In continuing their development, the synthesis and radiolabelling of the first DATA bifunctional chelator (BFC) and peptide conjugate are described. RESULTS: = 10.3 min). Kit-type labelling from a lyophilised solid using acetone-PP based labelling achieves > 95 % RCY in 10 min at 23 °C. CONCLUSIONS: Ga-DATATOC can be prepared makes it a very attractive alternative to current standards.
37
Processing of Generator-Produced 68Ga for Medical Application
Konstantin Zhernosekov, D. V. Filosofov, Richard P. Baum et al. · Journal of Nuclear Medicine · 2007 · 504 citations · Full text
Irene Virgolini, Valentina Ambrosini, Jamshed Bomanji et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2010 · 447 citations